Mar 2, 2021 Cellectar Reports Financial Results for Year Ended December 31, 2020 and Provides a Corporate Update Learn More
Jan 27, 2021 Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Waldenstrom’s Macroglobulinemia Learn More